<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One hundred and ten previously untreated patients with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were studied prospectively over a period ranging from over 1 year to 5 years </plain></SENT>
<SENT sid="1" pm="."><plain>Of 103 patients who were treated with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> as a single agent, 79 (77%) achieved complete remission </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="28445">Vincristine</z:chebi> plus <z:chebi fb="0" ids="44185">methotrexate</z:chebi> or <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> induced complete remissions in only two of 24 patients who failed to respond to <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Fifty-two percent of patients who entered complete remission subsequently relapsed with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Relapse was significantly higher in patients who presented with disseminated disease (Stage III-IV) than in patients with <z:e sem="disease" ids="C0277565" disease_type="Disease or Syndrome" abbrv="">localized disease</z:e> (Stage I-II) </plain></SENT>
<SENT sid="5" pm="."><plain>Patients who relapsed early (remission duration less than 12 weeks) had a significantly worse prognosis than patients who relapsed late (remission duration greater than 12 weeks) </plain></SENT>
<SENT sid="6" pm="."><plain>Actuarial calculated 2- and 4-year survival for <z:hpo ids='HP_0000001'>all</z:hpo> patients was 44% and 38%, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Factors that adversely affected survival were primary resistance to <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, early <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> relapse, central <z:mp ids='MP_0008912'>nervous</z:mp> system disease, and involvement of abdominal organs </plain></SENT>
</text></document>